Dc Investments Management, LLC Mirum Pharmaceuticals, Inc. Transaction History
Dc Investments Management, LLC
- $151 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$297 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$207 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$146 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$126 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$118 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.66B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...